26Indexed trials
mesh condition
Mood Disorders
Intelligence
Mood Disorders intelligence: 26 indexed trials, 3 recruiting studies, 24 sponsors across 8 countries.
3Recruiting
24Sponsors
8Countries
Leading sponsors
National Institute of Mental Health (NIMH)20 recruiting
University of Michigan20 recruiting
GlaxoSmithKline10 recruiting
H. Lundbeck A/S10 recruiting
Hospices Civils de Lyon10 recruiting
Johns Hopkins University10 recruiting
Shalvata Mental Health Center10 recruiting
St. Joseph's Healthcare Hamilton10 recruiting
University Hospital, Toulouse10 recruiting
University of California, Los Angeles10 recruiting
University of Guelph11 recruiting
University of Massachusetts, Worcester10 recruiting
Geographic activity
United States15trials
Canada3trials
Australia2trials
France2trials
United Kingdom2trials
Italy1trials
China1trials
Germany1trials
Leading interventions
Activation of personal and social resources1trials
Add-on citalopram following optimized methylphenidate1trials
Add-on placebo following optimized methylphenidate1trials
Brainsway H4-Coil Deep TMS System1trials
Brainsway H7-Coil Deep TMS System1trials
Cardiovascular Assessments1trials
Chinese translated LETS ACT1trials
Chronic Care Model for Mood Disorders1trials
Citalopram1trials
Cognitive restructuring of diabetes-related problems1trials
Computerized self-help program for depression1trials
Actigraphy1trials
Methodology note
This entity is derived from structured ClinicalTrials.gov conditions and/or MeSH normalization. Counts reflect the current NeuroRisk indexed corpus and are not guaranteed exhaustive global totals.